文献速递前列腺增生与排尿功能障碍

单次注射富血小板血浆治疗女性压力性尿失禁:随机安慰剂对照试验

A Single Injection of Platelet-rich Plasma Injection for the Treatment of Stress Urinary Incontinence in Females: A Randomized Placebo-controlled Trial.
PubMed 文献 · Urology · 2024-06-26

该单盲随机安慰剂对照试验在单中心纳入50例压力性为主的女性尿失禁患者,随机接受尿道中段阴道前壁注射5 mL自体富血小板血浆(PRP)或生理盐水,各25例。主要结局为6个月时复合治疗成功,两组无统计学显著差异,不良事件轻微且两组发生率相似。作者认为目前证据不足以提供单次PRP注射治疗女性压力性尿失禁。

要点

  • 单次尿道中段阴道前壁注射5 mL PRP与生理盐水相比,6个月复合治疗成功率无统计学显著差异。
  • 两组不良事件均轻微,且不良事件发生率相似。
  • 作者认为目前证据不足以提供单次PRP注射用于女性压力性尿失禁治疗。

核心结论

  • 在这项随机安慰剂对照研究中,未能证明PRP注射与生理盐水注射在压力性尿失禁治疗成功率上存在差异。
  • 作者认为目前证据不足以提供单次阴道前壁PRP注射治疗女性压力性尿失禁。

研究设计与样本

  • 单盲、随机、安慰剂对照临床试验,在单中心开展。
  • 纳入有困扰且可证实的以压力性为主的女性尿失禁患者,随机接受尿道中段阴道前壁注射5 mL自体PRP或生理盐水。
  • 共纳入50例患者,PRP组25例,生理盐水安慰剂组25例。
  • 主要结局为6个月时复合治疗成功,定义为咳嗽压力试验阴性且患者整体改善印象评分为「好很多」或「非常好」。

主要发现

  • 主要结局在PRP组与生理盐水安慰剂组之间无统计学显著差异。
  • 不良事件轻微,且不良事件发生率在两组间相似。

临床怎么用

  • 作者认为目前证据不足以提供单次阴道前壁PRP注射用于女性压力性尿失禁的治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the efficacy of a single injection of platelet-rich plasma (PRP) into the anterior vaginal wall at the mid-urethra compared to placebo, as there is emerging evidence that PRP may help treat female stress urinary incontinence (SUI). METHODS: This was a single-blind, randomized, placebo-controlled clinical trial at a single institution. Females with bothersome, demonstrable stress-predominant urinary incontinence were enrolled. Participants were randomized to either injection of 5 mL autologous PRP or saline at the anterior vaginal wall at the mid-urethra. The primary outcome was composite treatment success at 6 months, defined as a negative cough stress test and an answer of "much better" or "very much better" on the Patient's Global Impression of Improvement. RESULTS: Fifty patients were enrolled in the study and randomized to the PRP group (n = 25) or the saline placebo group (n = 25). There was no statistically significant difference in the primary outcome between the 2 groups. Adverse events were minor, and the rate of adverse events was similar between both groups. CONCLUSION: In this randomized placebo-controlled study, we were unable to demonstrate a difference in SUI treatment success between PRP and saline injections. At this time, there is insufficient evidence to offer a one-time PRP injection into the anterior vaginal wall for treatment of female SUI.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Ashton L, Nakatsuka H, Johnson CM, et al. A Single Injection of Platelet-rich Plasma Injection for the Treatment of Stress Urinary Incontinence in Females: A Randomized Placebo-controlled Trial. Urology. 2024. PMID: 38942391. doi:10.1016/j.urology.2024.06.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。